Spectrum Brands
SPB
76.95
+0.23
+0.30%
Spectrum Brands
US · SPB
#2881 by market cap
Listed 1970
76.95
+0.23
+0.30%
Live - 5344 symbols - heartbeat 422s ago
· 2026-10-08 07:00
Pre-market
76.78
-0.23%
After-hours
76.95
0.00%
- Market cap
- 1.77B
- P/E (TTM)i
- 24.12
- P/Bi
- 0.96
- EPSi
- 3.86
- Div yieldi
- 2.44%
- 52W posi
- 57%
Reader sentiment
Are you bullish or bearish on SPB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.85, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -5.23% YoY
Margins
- Gross margin
- 36.74%
- Operating margin
- 5.32%
- Net margin
- 3.56%
Key ratios & quality
- Enterprise valuei
- 2.25B
- PEG ratioi
- 2.05
- Altman Z-Scorei
- 2.85
PEG uses trailing P/E against the 3-year net income growth rate (11.74%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.81B | 2.45B | 2.62B | 3.00B | 3.13B | 2.92B | 2.96B | 2.81B |
| Gross profit | 1.33B | 819.60M | 878.10M | 1.03B | 990.40M | 924.30M | 1.11B | 1.03B |
| Selling & admin expenses | 943.00M | 709.10M | 789.30M | 907.70M | 995.70M | 888.80M | 953.40M | 882.60M |
| Research & development | 44.60M | 32.10M | 29.20M | 29.80M | -- | -- | -- | -- |
| Operating profit | 346.70M | 78.40M | 59.60M | 97.10M | -5.30M | 35.50M | 155.90M | 149.30M |
| Pretax profit | -35.70M | -354.20M | -25.10M | -11.10M | -90.30M | -290.20M | 163.60M | 87.20M |
| Tax | -462.70M | -52.00M | 27.30M | -26.40M | -13.30M | -56.50M | 64.30M | -13.00M |
| Net profit | 872.00M | 495.80M | 98.50M | 189.60M | 72.70M | 1.80B | 124.80M | 100.40M |
| Basic EPS | 21 | 10 | 2 | 4 | 2 | 46 | 4 | 4 |
| Diluted EPS | 20.74 | 9.76 | 2.19 | 4.39 | 1.75 | 45.65 | 4.10 | 3.86 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 675.70M | 699.60M | 733.50M | 677.00M | 708.90M | 753.30M |
| Gross profit | 253.40M | 264.10M | 256.60M | 241.60M | 270.30M | 370.40M |
| Selling & admin expenses | 206.10M | 212.80M | 261.60M | 205.70M | 212.10M | 237.50M |
| Research & development | 5.90M | 5.50M | -- | 5.00M | 5.70M | 6.20M |
| Operating profit | 41.40M | 45.80M | 12.10M | 30.90M | 52.50M | 126.70M |
| Pretax profit | 11.40M | 22.00M | 17.40M | 20.50M | 36.80M | 8.50M |
| Tax | 9.60M | 1.50M | -35.90M | -8.90M | 14.30M | 28.80M |
| Net profit | 1.20M | 19.70M | 55.70M | 28.40M | 22.10M | -21.50M |
| Basic EPS | 0 | 1 | 2 | 1 | 1 | -1 |
| Diluted EPS | 0.03 | 0.80 | 2.29 | 1.21 | 0.94 | -1.16 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.97B | 1.66B | 1.73B | 2.91B | 3.24B | 2.93B | 1.58B | 1.18B |
| Cash & ST investments | 552.50M | 627.10M | 531.60M | 187.90M | 243.70M | 1.86B | 368.90M | 123.60M |
| Inventory | 583.60M | 548.40M | 318.60M | 562.80M | 780.60M | 462.80M | 462.10M | 446.10M |
| Total assets | 7.80B | 5.25B | 5.11B | 5.34B | 5.78B | 5.26B | 3.84B | 3.38B |
| Total current liabilities | 1.43B | 1.14B | 944.90M | 1.16B | 1.19B | 764.80M | 687.10M | 523.20M |
| Short-term debt | 26.90M | 136.90M | 13.90M | 12.00M | 12.30M | 8.60M | 40.70M | 43.50M |
| Long-term debt | 4.62B | 2.21B | 2.31B | 2.49B | 3.14B | 1.55B | 551.40M | 556.20M |
| Total liabilities | 6,209,400,000.00 | 3,517,100,000.00 | 3,691,500,000.00 | 3,861,400,000.00 | 4,506,500,000.00 | 2,740,100,000.00 | 1,700,600,000.00 | 1,469,900,000.00 |
| Total equity | 1.59B | 1.73B | 1.42B | 1.48B | 1.27B | 2.52B | 2.14B | 1.91B |
| Retained earnings | -180.10M | 223.80M | 243.90M | 359.90M | 362.10M | 2.10B | 2.17B | 2.22B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.34B | 1.34B | 1.18B | 1.20B | 1.27B | 1.50B |
| Cash & ST investments | 96.00M | 122.00M | 123.60M | 126.60M | 125.10M | 258.90M |
| Inventory | 542.60M | 507.50M | 446.10M | 450.80M | 487.10M | 499.60M |
| Total assets | 3.54B | 3.54B | 3.38B | 3.42B | 3.47B | 3.58B |
| Total current liabilities | 573.10M | 553.10M | 523.20M | 542.20M | 554.30M | 621.80M |
| Short-term debt | 9.50M | 42.60M | 43.50M | 31.80M | 32.90M | 32.20M |
| Long-term debt | 632.00M | 655.90M | 556.20M | 554.30M | 575.90M | 603.60M |
| Total liabilities | 1,651,700,000.00 | 1,648,500,000.00 | 1,469,900,000.00 | 1,523,600,000.00 | 1,573,200,000.00 | 1,729,000,000.00 |
| Total equity | 1.89B | 1.89B | 1.91B | 1.90B | 1.90B | 1.85B |
| Retained earnings | 2.17B | 2.18B | 2.22B | 2.24B | 2.25B | 2.21B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 352.50M | 1.10M | 290.30M | 288.40M | -53.80M | -409.70M | 162.60M | 203.60M |
| Depreciation & amortization | 124.60M | 147.30M | 114.60M | 117.00M | 99.30M | 91.20M | 101.80M | 98.00M |
| Free cash flow | 276.60M | -39.30M | 246.20M | 244.80M | -117.80M | -468.70M | 118.60M | 165.30M |
| Dividends paid | -374.20M | -85.50M | -75.20M | -71.50M | -68.60M | -66.50M | -50.60M | -48.20M |
| Stock buybacks / issuance | -- | -268.50M | -364.80M | -125.80M | -134.00M | -534.70M | -482.70M | -326.40M |
| Ending cash balance | 514.30M | 627.10M | 533.70M | 190.00M | 243.90M | 753.90M | 370.50M | 127.20M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 23.10M | 81.80M | 171.10M | 67.40M | 10.20M | 83.30M |
| Depreciation & amortization | 24.50M | 25.10M | 23.90M | 25.80M | 24.20M | 24.80M |
| Free cash flow | 13.90M | 71.80M | 157.90M | 59.30M | 900.00K | 73.50M |
| Dividends paid | -12.10M | -11.60M | -11.30M | -10.90M | -10.90M | -10.80M |
| Stock buybacks / issuance | -159.90M | -54.40M | -39.20M | -35.50M | -6.80M | -15.90M |
| Ending cash balance | 98.20M | 125.50M | 127.20M | 130.10M | 128.60M | 262.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 65.69 | 28.78 | 6.30 | 13.17 | 5.24 | 95.30 | 5.36 | 4.93 |
| ROA %i | 3.52 | 7.27 | 1.89 | 3.63 | 1.29 | 32.65 | 2.74 | 2.77 |
| ROIC %i | 15.04 | 13.31 | 5.07 | 6.87 | 3.68 | 43.33 | 3.61 | 4.49 |
| 5-year avg ROE %i | -2.85 | 4.69 | 16.92 | 26.05 | 24.06 | 29.98 | 25.06 | 24.80 |
| EBIT margin %i | 3.44 | 0.74 | 7.57 | 3.52 | 0.29 | -5.59 | 7.49 | 4.17 |
| FCF / sales %i | 8.85 | -- | 0.48 | 8.17 | -- | -- | 4.00 | 5.88 |
| Current ratioi | 2.78 | 1.46 | 1.83 | 2.50 | 2.72 | 3.83 | 2.30 | 2.26 |
| Quick ratioi | 0.64 | 0.93 | 0.93 | 0.43 | 0.49 | 3.16 | 1.56 | 1.33 |
| Debt / assetsi | 59.64 | 44.82 | 48.34 | 47.76 | 55.63 | 31.40 | 17.67 | 19.36 |
| LT debt / equityi | 292.44 | 128.68 | 174.44 | 172.48 | 253.36 | 65.24 | 29.82 | 31.98 |
| Interest coveragei | 0.41 | 0.13 | 2.08 | 0.90 | 0.09 | -1.29 | 3.80 | 3.91 |
| Revenue CAGR (3Y) %i | -7.12 | -6.97 | -10.90 | -7.67 | 8.59 | 3.64 | -0.38 | -3.57 |
| Net income CAGR (3Y) %i | -- | -- | -2.65 | -37.28 | -47.49 | 164.10 | -13.01 | 11.74 |
| FCF CAGR (3Y) %i | 6.94 | -- | -31.27 | -3.99 | -- | -- | -21.46 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 2.85 | 3.66 | 4.93 | 5.34 | 6.66 | 4.24 |
| ROA %i | 1.42 | 2.00 | 2.77 | 2.98 | 3.59 | 2.23 |
| ROIC %i | 2.27 | 3.27 | 4.49 | 4.83 | 5.47 | 3.64 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.85 | 4.05 | 4.17 | 3.66 | 4.51 | 3.95 |
| FCF / sales %i | 2.59 | 2.64 | 5.88 | 10.87 | 10.28 | 10.15 |
| Current ratioi | 2.34 | 2.42 | 2.26 | 2.21 | 2.29 | 2.41 |
| Quick ratioi | 1.31 | 1.42 | 1.33 | 1.29 | 1.34 | 1.54 |
| Debt / assetsi | 20.24 | 21.45 | 19.36 | 20.38 | 20.88 | 20.91 |
| LT debt / equityi | 37.48 | 37.88 | 31.98 | 35.06 | 36.44 | 38.73 |
| Interest coveragei | 3.94 | 4.01 | 3.91 | 3.33 | 4.18 | 3.75 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Home and Personal Care (HPC) is the largest reported line at 35.10% of revenue, across 3 reported segments.
- No single line clears half of revenue; Global Pet Care (GPC) is next at 35.01%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Home and Personal Care (HPC)35.10%
Global Pet Care (GPC)35.01%
Home and Garden (H&G)29.90%
Quote time 2026-10-08 07:00:16 · For reference only, not investment advice and not tailored to your situation.